✦ LIBER ✦

Small-Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer Therapeutics

✍ Scribed by Jeremy L. Yap; Dr. Shilpa Worlikar; Prof. Dr. Alexander D. MacKerell Jr.; Prof. Dr. Paul Shapiro; Prof. Dr. Steven Fletcher

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 633 KB
Volume: 6
Category: Article
ISSN: 1860-7179
DOI: 10.1002/cmdc.201000354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Small-Molecule Inhi

ChemInform Abstract: Small-Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer Therapeutics

✍ Jeremy L. Yap; Shilpa Worlikar; Alexander D. MacKerell; Paul Jr. Shapiro; Steven 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 18 KB 👁 2 views

Small-Molecule Inhibitors of the Hedgeho

Small-Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics

✍ Stefan Peukert; Karen Miller-Moslin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

ChemInform Abstract: Small-Molecule Inhi

ChemInform Abstract: Small-Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics

✍ Stefan Peukert; Karen Miller-Moslin 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 15 KB 👁 1 views

Exploring the biological space of FOXO r

Exploring the biological space of FOXO regulation: discovery of therapeutic targets and small molecule inhibitors for anticancer therapy

✍ W. Link 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 61 KB

Inhibition of Flt3-activating mutations

Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: a possible cause for the limited effectiveness of monotherapy with small-molecule inhibitors

✍ Emilio Siendones; Nuria Barbarroja; Luis Arístides Torres; Paula Buendía; Franci 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

## Abstract The Flt3 receptor tyrosine kinase is a critical mediator in the pathogenesis of acute myeloid leukaemia (AML). Flt3‐activating mutations have been associated with poor prognosis and decreased overall survival of AML patients, thus Flt3 constitutes an ideal target for drug treatment of s